A natural heparinoid from mollusc Meretrix lusoria: Purification, structural characterization, and antithrombotic evaluation

Andrade, 2013, A heparin-like compound isolated from a marine crab rich in glucuronic acid 2-O-sulfate presents low anticoagulant activity, Carbohydr. Polym., 94, 647, 10.1016/j.carbpol.2013.01.069 Arumugam, 2014, Biological activities of heparan sulfate, Adv. Food Nutr. Res., 72, 125, 10.1016/B978-0-12-800269-8.00008-7 Brito, 2008, Anti-inflammatory properties of a heparin-like glycosaminoglycan with reduced anti-coagulant activity isolated from a marine shrimp, Bioorg. Med. Chem., 16, 9588, 10.1016/j.bmc.2008.09.020 Brito, 2014, A non-hemorrhagic hybrid heparin/heparan sulfate with anticoagulant potential, Carbohydr. Polym., 99, 372, 10.1016/j.carbpol.2013.08.063 Chavante, 2014, A heparin-like glycosaminoglycan from shrimp containing high levels of 3-O-sulfated D-glucosamine groups in an unusual trisaccharide sequence, Carbohydr. Res., 390, 59, 10.1016/j.carres.2014.03.002 Chen, 2021, Preparation, physicochemical properties and anticoagulant activity of heparinoid from shrimp head, Food Sci. (N. Y.), 42, 71 Cheng, 2017, Anti-angiogenic activity and antitumor efficacy of amphiphilic twin drug from ursolic acid and low molecular weight heparin, Nanotechnology, 28, 10.1088/1361-6528/aa53c6 Colliec-Jouault, 2012, Heparin-like entities from marine organisms, Handb. Exp. Pharmacol., 207, 423, 10.1007/978-3-642-23056-1_19 Dietrich, 1999, Structural features and anticoagulant activities of a novel natural low molecular weight heparin from the shrimp Penaeus brasiliensis, Biochim. Biophys. Acta Gen. Subj., 1428, 273, 10.1016/S0304-4165(99)00087-2 Domanig, 2009, One-dimensional cellulose acetate plate electrophoresis--a feasible method for analysis of dermatan sulfate and other glycosaminoglycan impurities in pharmaceutical heparin, J. Pharm. Biomed. Anal., 49, 151, 10.1016/j.jpba.2008.10.017 Du, 2018 Du, 2019, Isolation and characterization of a heparin-like compound with potent anticoagulant and fibrinolytic activity from the clam coelomactra antiquata, Mar. Drugs, 18, 6, 10.3390/md18010006 Du, 2019, Physicochemical properties and anticoagulant activity of heparin from different marine organisms, Food Sci. (N. Y.), 17, 134 Duan, 2018, Study on effects of different molecular weight Apostichopus japonicus glycosaminoglycans on the activity of fibrinolytic system in rats, Chin. J. Mar. Drugs, 37, 1 Flengsrud, 2010, Purification, characterization and in vivo studies of salmon heparin, Thromb. Res., 126, e409, 10.1016/j.thromres.2010.07.004 Fu, 2013, Structural characterization of pharmaceutical heparins prepared from different animal tissues, J. Pharm. Sci., 102, 1447, 10.1002/jps.23501 Gomes, 2015, Antitumor properties of a new non-anticoagulant heparin analog from the mollusk Nodipecten nodosus: effect on P-selectin, heparanase, metastasis and cellular recruitment, Glycobiology, 25, 386, 10.1093/glycob/cwu119 Gorog, 2022, Current and novel biomarkers of thrombotic risk in COVID-19: a consensus statement from the international COVID-19 thrombosis biomarkers colloquium, Nat. Rev. Cardiol., 10.1038/s41569-021-00665-7 Hippensteel, 2020, Heparin as a therapy for COVID-19: current evidence and future possibilities, Am. J. Physiol. Lung Cell Mol. Physiol., 319, L211, 10.1152/ajplung.00199.2020 Kohler, 2000, Plasminogen-activator inhibitor type 1 and coronary artery disease, N. Engl. J. Med., 342, 1792, 10.1056/NEJM200006153422406 Kozlowski, 2011, Structure and biological activities of glycosaminoglycan analogs from marine invertebrates: new therapeutic agents?, 159 Li, 2006 Li, 2017, Structure and anticoagulant property of a sulfated polysaccharide isolated from the green seaweed Monostroma angicava, Carbohydr. Polym., 159, 195, 10.1016/j.carbpol.2016.12.013 Lindahl, 2005, Generation of "neoheparin" from E. coli K5 capsular polysaccharide, J. Med. Chem., 48, 349, 10.1021/jm049812m Liu, 2018, Extraction and detailed characterization of phospholipid-enriched oils from six species of edible clams, Food Chem., 239, 1175, 10.1016/j.foodchem.2017.07.035 Liu, 2020, Evaluation and improvement of in vitro detection methods of thrombin inhibitor activity, eFood, 1, 377, 10.2991/efood.k.201002.001 Medeiros, 2000, Distribution of sulfated glycosaminoglycans in the animal kingdom: widespread occurrence of heparin-like compounds in invertebrates, Biochim. Biophys. Acta Gen. Subj., 1475, 287, 10.1016/S0304-4165(00)00079-9 Micco, 2022, Thrombotic disorders and antithrombotic treatments special issue, Medicina (Kaunas), 58, 229, 10.3390/medicina58020229 Monakhova, 2018, Authentication of animal origin of heparin and low molecular weight heparin including ovine, porcine and bovine species using 1D NMR spectroscopy and chemometric tools, J. Pharm. Biomed. Anal., 149, 114, 10.1016/j.jpba.2017.10.020 Mulloy, 2019, The non-anticoagulant promise of heparin and its mimetics, Curr. Opin. Pharmacol., 46, 50, 10.1016/j.coph.2019.03.009 Palhares, 2019, A further unique chondroitin sulfate from the shrimp Litopenaeus vannamei with antithrombin activity that modulates acute inflammation, Carbohydr. Polym., 222, 10.1016/j.carbpol.2019.115031 Pan, 2018, Glycosaminoglycans from fish swim bladder: isolation, structural characterization and bioactive potential, Glycoconj. J., 35, 87, 10.1007/s10719-017-9804-5 Pavão, 2012, Challenges for heparin production: artificial synthesis or Alternative Natural sources?, Glycobiol. Insights, 3, 1, 10.4137/GBI.S9705 Qiu, 2021, Pharmacological and clinical application of heparin progress: an essential drug for modern medicine, Biomed. Pharmacother., 139, 10.1016/j.biopha.2021.111561 Santos, 2007, Isolation and characterization of a heparin with low antithrombin activity from the body of Styela plicata (Chordata-Tunicata). Distinct effects on venous and arterial models of thrombosis, Thromb. Res., 121, 213, 10.1016/j.thromres.2007.03.025 Saravanan, 2010, Glycosaminoglycans from marine clam Meretrix meretrix (Linne.) are an anticoagulant, Prep. Biochem. Biotechnol., 40, 305, 10.1080/10826068.2010.488998 Shan, 2019, Efficacy of heparinoid PSS in treating cardiovascular diseases and beyond—a review of 31 years clinical experiences in China, 75 Tage Astrup, 1952, The fibrin plate method for estimating fibrinolytic activity, Arch. Biochem. Biophys., 40 Valcarcel, 2017, Glycosaminoglycans from marine sources as therapeutic agents, Biotechnol. Adv., 35, 711, 10.1016/j.biotechadv.2017.07.008 Vazhappilly, 2019, Role of flavonoids in thrombotic, cardiovascular, and inflammatory diseases, Inflammopharmacology, 27, 863, 10.1007/s10787-019-00612-6 Wang, 2013 Wang, 2017, Purification, characterization, and antioxidant activity of polysaccharides isolated from cortex periplocae, Molecules, 22, 1866, 10.3390/molecules22111866 Wang, 2018, Abundance of saccharides and scarcity of glycosaminoglycans in the soft tissue of clam, Meretrix meretrix (Linnaeus), Acta Histochem., 120, 551, 10.1016/j.acthis.2018.07.001 Wang, 2019, Elaboration in type, primary structure, and bioactivity of polysaccharides derived from mollusks, Crit. Rev. Food Sci. Nutr., 59, 1091, 10.1080/10408398.2017.1392289 Wegrowski, 2001, Cellulose acetate electrophoresis of glycosaminoglycans, Methods Mol. Biol., 171, 175 Yang, 2018, Separation, purification, structures and anticoagulant activities of fucosylated chondroitin sulfates from Holothuria scabra, Int. J. Biol. Macromol., 108, 710, 10.1016/j.ijbiomac.2017.11.058 Yates, 1996, 1H and 13C NMR spectral assignments of the major sequences of twelve systematically modified heparin derivatives, Carbohydr. Res., 294, 15, 10.1016/S0008-6215(96)90611-4 Zhang, 1999 Zhao, 2020, The algal polysaccharide ulvan suppresses growth of hepatoma cells, Food Front., 1, 83, 10.1002/fft2.13